The intradermal injection market is projected to grow from USD 5.3 billion in 2025 to USD 14.7 billion by 2035, at a CAGR of 10.8%. Normal Sized Needles will dominate with a 36.7% market share, while tuberculin skin test will lead the application segment with a 42.3% share.